Our new study, spearheaded by Humberto Ferreira, is available online. We delve into the detection of HLA peptides that may originate from the translation of circRNAs. Special thanks to the Alexey Nesvizhskii for setting up the group-specific FDR control in FragPipe nature.com/articles/s4146…

💡NEW STUDY about #NeoDisc: a cutting-edge tool for neoantigen discovery in personalized cancer #immunotherapy in Nature Biotechnology by Michal Bassani-Sternberg Florian Huber et al. Ludwig Cancer CHUV / Centre hospitalier universitaire vaudois Université de Lausanne 🔗 nature.com/articles/s4158… ▶️news.unil.ch/display/172863…

Thank you Nature Biotechnology for the great overview on NeoDisc in the Research briefing nature.com/articles/s4158…

A comprehensive proteogenomic pipeline for neoantigen discovery to advance personalized cancer immunotherapy go.nature.com/4eEVVvo

Scientists led by Ludwig Oncology UNIL CHUV's Florian Huber & Michal Bassani-Sternberg report NeoDisc, a computational pipeline that integrates molecular/genetic analyses of tumors + targets of T cells and harnesses AI to design personalized cancer vaccines. bit.ly/4eFqe59

New online in Nature Biotechnology by Michal Bassani-Sternberg group: The neoantigen discovery pipeline NeoDisk incorporates mass spectrometry immunopeptidomics data. Florian Huber Oncology UNIL CHUV Ludwig Cancer CHUV / Centre hospitalier universitaire vaudois SIB

Wow, NeoDisc is an amazing pipeline that characterizes neoantigens, TAAs, TSAs, viral antigens, and antigen presentation defects with genomic, transcriptomic, immunopeptidomic data. It includes TE expression 🤯! Congrats to the pioneer Michal Bassani-Sternberg, Florian Huber , and team!

Michal Bassani-Sternberg Florian Huber Oncology UNIL CHUV Ludwig Cancer CHUV / Centre hospitalier universitaire vaudois SIB NeoDisc pipeline enables personalised cancer immunotherapy #NBTintheNews via World Vaccine Congress vaccinenation.org/technology/neo…

Michal Bassani-Sternberg Florian Huber Oncology UNIL CHUV Ludwig Cancer CHUV / Centre hospitalier universitaire vaudois SIB World Vaccine Congress Comprehensive AI-enabled pipeline aids development of personalized cancer vaccines #NBTintheNews via Inside Precision Medicine insideprecisionmedicine.com/topics/oncolog…

Check out the latest issue of eLudwigNews conta.cc/3Ubkho4 and sign up for our newsletter to stay up to date on all Ludwig news bit.ly/LCRnews

🧵Transforming Tumors into Targets Nature Biotechnology! NeoDisc pipeline by researchers at the University of Lausanne, Switzerland combines genomics, transcriptomics, and immunopeptidomics to identify the best cancer antigens for personalized immunotherapy: nature.com/articles/s4158…

Our #diaTracer manuscript is out! 10 years ago we established the concept of library-free, direct DIA analysis with DIA-Umpire. DiaTracer now makes it possible to analyze any diaPASEF data, including PTM, semi-tryptic, nonspecific, and even open searches! nature.com/articles/s4146…